NCT06079619
- Conditions
- Genital Tumor, Hyperpigmentation, Melanoma, +15 more
- Locations
-
- CHU Saint Etienne Saint-Etienne, France
Clinical trial condition
Neuroectodermal Tumors
Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.
6,011 public trials
1,221 recruiting studies
Neuroectodermal Tumors trial results
NCT03326388
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
- Locations
-
- Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom
- Great Ormond Street Hospital NHS Foundatin Trust London, United Kingdom
NCT00445965
- Conditions
- Adnexal Diseases, Astrocytoma, Brain Diseases, +88 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00589875
- Conditions
- Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +11 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- The University of Chicago Chicago, Illinois, United States
- The Ohio State University Medical Center, Dept. Neurological Surgery Columbus, Ohio, United States
- The Methodist Hospital Neurological Institute Houston, Texas, United States
NCT03925246
- Conditions
- Brain Cancer, Brain Diseases, Brain Neoplasms, +14 more
- Locations
-
- Groupe Hospitalier Saint-André Bordeaux, France
- Hospices Civils de Lyon, Hôpital Pierre Wertheimer Bron, France
- AP-HM, La Timone, Hôpital Universitaire Marseille, France
- Institut de Cancérologie de l'Ouest (ICO) - site CLCC René Gauducheau Nantes, France
NCT03454295
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +7 more
- Locations
-
- Memorial Sloan Kettering Commack (Consent only) Commack, New York, United States
- Memorial Sloan Kettering Westchester (Consent only) Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT03466450
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +7 more
- Locations
-
- Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
- Hospital del Mar Barcelona, Spain
- Hospital Clínic i Provincial de Barcelona Barcelona, Spain
- Institut Catalá de Oncología Girona/Hospital Universitari Dr. Josep Trueta Girona, Spain
Completed
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
NCT03329950
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
- Locations
-
- HonorHealth Research Insititute Scottsdale, Arizona, United States
- Northside Hospital, Inc. Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
Completed
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
NCT02052648
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
- Locations
-
- Eden Medical Center Castro Valley, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- UC Irvine Chao Family Comprehensive Cancer Center Orange, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
Completed
Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies
NCT03590054
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +57 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States